SCHEMBL2909849

SCHEMBL2909849

O=C(NC1CCCCC1)C(C1CCCCC1)C1(Cc2ccc(F)cc2F)Nc2cc(F)c(F)cc2N1

nearest known ligand 0.46

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 9/20 0.46
RAB9A P51151 9/20 0.46
POLB P06746 1/20 0.46
IDO1 P14902 1/20 0.37
SIGMAR1 Q99720 1/20 0.37
SMN1; SMN2 Q16637 4/20 0.37
MLLT1 Q03111 1/20 0.36
EPHX1 P07099 1/20 0.36
ALDH1A1 P00352 2/20 0.36
LMNA P02545 1/20 0.36
MEN1 O00255 1/20 0.36
GAA P10253 1/20 0.36
KMT2A Q03164 1/20 0.36
HTR2B P41595 1/20 0.36
ACKR3 P25106 1/20 0.36
CNR1 P21554 2/20 0.36
CNR2 P34972 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2912992 0.95 NPC1 (0.45) NPC1RAB9APOLBIDO1SIGMAR1
SCHEMBL2907059 0.85 C3AR1 (0.39) NPC1RAB9APOLBSMN1; SMN2EPHX1
SCHEMBL3651333 0.81 NPC1 (0.42) NPC1RAB9APOLBSMN1; SMN2EPHX1
SCHEMBL2912657 0.79 EPHX2 (0.51) NPC1RAB9ASIGMAR1EPHX1LMNA
SCHEMBL3648066 0.79 KMT2A (0.38) NPC1RAB9APOLBSIGMAR1SMN1; SMN2
SCHEMBL3649621 0.79 NPC1 (0.40) NPC1RAB9APOLBIDO1SMN1; SMN2
SCHEMBL2914994 0.78 MEN1 (0.48) NPC1RAB9APOLBEPHX1LMNA
SCHEMBL2912514 0.78 TP53 (0.40) NPC1RAB9APOLBIDO1SMN1; SMN2
SCHEMBL2909783 0.78 LMNA (0.46) NPC1RAB9ASMN1; SMN2ALDH1A1LMNA
SCHEMBL3654059 0.78 EPHX1 (0.44) NPC1RAB9ASMN1; SMN2EPHX1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2222645-A2 BENZIMIDAZOLE DERIVATIVES AND THEIR USE AS FXR AGONISTS F. Hoffmann-La Roche AG (CH) 2010-09-01 EP claimed
WO-2009062874-A2 BENZIMIDAZOLE DERIVATIVES AND THEIR USE AS FXR AGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2009-05-22 WO claimed
EP-2222645-A2 BENZIMIDAZOLE DERIVATIVES AND THEIR USE AS FXR AGONISTS F. Hoffmann-La Roche AG (CH) 2010-09-01 EP disclosed
WO-2009062874-A2 BENZIMIDAZOLE DERIVATIVES AND THEIR USE AS FXR AGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2009-05-22 WO disclosed